In MS, immune system cells mistakenly attack myelin. With stem cell treatment, doctors use chemotherapy to destroy these existing immune cells. Then, they introduce the new stem cells, which are ...

The reported evidence of neurodegeneration in multiple sclerosis ... of each stem cell type for future clinical applications in MS. Therefore, it is obvious that, in order to improve treatment ...

While there’s no cure for multiple ... No stem cell therapies for MS are currently approved by the FDA. According to one research review, mesenchymal stem cell (MSC) therapy may help reduce ...

ECTRIMS and EBMT said stem cell transplant can be considered for some with RRMS, such as those who are younger and have less ...

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

The following is a summary of “Chronic graft-versus-host disease myelitis successfully treated with rituximab,” published in ...

DIABETES, Parkinson's disease, degenerative disc disease, macular degeneration, stroke — what do these have in common? Besides being relatively debilitating conditions, all of these have been treated ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell treatments ... Parkinson’s, multiple sclerosis and even erectile dysfunction.

The use of stem cells may open a new era in the management of multiple sclerosis (MS) and other neurodegenerative and neuroimmunological disorders. In the case of MS, the potential of stem cells ...